PMC:7696151 / 30462-30757 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"905","span":{"begin":72,"end":80},"obj":"Species"},{"id":"989","span":{"begin":63,"end":71},"obj":"Disease"}],"attributes":[{"id":"A905","pred":"tao:has_database_id","subj":"905","obj":"Tax:9606"},{"id":"A989","pred":"tao:has_database_id","subj":"989","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"-label, randomized controlled trial involving 150 hospitalized infected patients (148 with mild or moderate disease and 2 with severe disease). All subjects were divided into two groups (in a 1:1 ratio): the control group that received only SOC, consisting of antiviral, glucocorticoid, and anti"}